These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14051560)

  • 1. [LONG-TERM TREATMENT OF CHRONIC LIVER DISEASES WITH PREDNISOLONE AND METHANDROSTENOLONE. PRELIMINARY REPORT].
    FRANKEN FH; DAWEKE H; GRIES EA; SCHWEINITZ HA; HOLZGREWE H; FORSTMANN U
    Dtsch Med Wochenschr; 1963 Oct; 88():1979-85. PubMed ID: 14051560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anabolic steroids in the treatment of liver diseases].
    Mossor-Ostrowska J
    Pol Tyg Lek; 1971 Aug; 26(32):1248-51. PubMed ID: 4942579
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE METABOLIC EFFECT OF ANABOLIC STEROIDS AND THEIR CLINICAL APPLICATION].
    YOSHITOSHI Y
    Nihon Naibunpi Gakkai Zasshi; 1964 Dec; 40():1155-65. PubMed ID: 14267839
    [No Abstract]   [Full Text] [Related]  

  • 4. [NEROBOL OVERDOSAGE IN INFANCY AND CHILDHOOD].
    KASSAI S; MOLNAR M
    Gyermekgyogyaszat; 1963 Dec; 14():370-4. PubMed ID: 14097507
    [No Abstract]   [Full Text] [Related]  

  • 5. [TREATMENT OF CHRONIC HEPATITIS. 3. INFLUENCE OF ANABOLIC TESTOSTERONE DERIVATIVES ON THE EVOLUTION OF CHRONIC HEPATITIS].
    MARCUS N; RUNCAN V; MIRON C; CRETESCU R
    Stud Cercet Med Interna; 1964; 38():389-96. PubMed ID: 14212656
    [No Abstract]   [Full Text] [Related]  

  • 6. [The retention of BSF during treatment with a new synthetic anabolic agent: methandrostenolone].
    MASTRANDREA G; MAZZETTI M
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():48-50. PubMed ID: 14470994
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

  • 8. DECREASED ANTICOAGULANT TOLERANCE DURING METHANDROSTENOLONE THERAPY.
    PYOERAELAE K; KEKKI M
    Scand J Clin Lab Invest; 1963; 15():367-74. PubMed ID: 14073285
    [No Abstract]   [Full Text] [Related]  

  • 9. [PRELIMINARY TRIAL IN DERMATOLOGY OF A NEW COMPOUND OF DEXAMETHASONE AND AN ANABOLIC].
    MAZZINI MA
    Sem Med; 1963 Sep; 123():1060-1. PubMed ID: 14091141
    [No Abstract]   [Full Text] [Related]  

  • 10. USE OF METHANDROSTENOLONE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    HECKEL RV; CLARK DT; BERMAN M; HALL RC
    Dis Nerv Syst; 1964 Mar; 25():171-2. PubMed ID: 14127899
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF RENAL HYPERAZOTEMIA BY METHANDROSTENOLONE].
    GALDI R
    Riforma Med; 1964 Apr; 78():397-401. PubMed ID: 14154097
    [No Abstract]   [Full Text] [Related]  

  • 12. [VOICE CHANGES DURING TREATMENT WITH ANABOLIC STEROIDS].
    THOMSEN KA; ZILSTORFF-PEDERSEN K
    Ugeskr Laeger; 1963 Aug; 125():1166-7. PubMed ID: 14045854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anabolic steroids and the functional state of the liver].
    Volkov NF; Galkin LP; Petlitskiĭ SI; Stolpinskiĭ AA
    Ter Arkh; 1972 Dec; 44(12):71-5. PubMed ID: 4666355
    [No Abstract]   [Full Text] [Related]  

  • 14. [POTENTIATION OF THE ANTI-INFLAMMATORY EFFECT OF CORTICOSTEROIDS BY DIANABOL IN THE LONG-TERM TREATMENT OF BRONCHIAL ASTHMA].
    AEPLI R
    Schweiz Med Wochenschr; 1964 Jan; 94():53-7. PubMed ID: 14133471
    [No Abstract]   [Full Text] [Related]  

  • 15. [CLINICAL EXPERIMENTATION OF A PREPARATION FOR TOPICAL USE CONTAINING AN ANABOLIZING STEROID, METHANDROSTENOLONE, IN THE TREATMENT OF CUTANEOUS ULCERATIONS].
    GIACOMETTI F
    Rass Dermatol Sifilogr; 1964; 17():41-54. PubMed ID: 14141267
    [No Abstract]   [Full Text] [Related]  

  • 16. [LATEST OBSERVATIONS ON GYNECOMASTIA DUE TO METHANDROSTENOLONE].
    MORABITO F
    Clin Ter; 1964 Jun; 29():582-4. PubMed ID: 14182614
    [No Abstract]   [Full Text] [Related]  

  • 17. [STEROIDAL ETHERS: EFFECT OF SOME ANABOLIC STEROIDS ON THE GROWTH CURVE, BODY COMPOSITION AND WEIGHT OF VARIOUS ORGANS IN MALE CASTRATED RATS].
    ERCOLI A; GALLETTL F
    Boll Soc Ital Biol Sper; 1963 Dec; 39():2090-5. PubMed ID: 14156768
    [No Abstract]   [Full Text] [Related]  

  • 18. PROTEIN METABOLISM IN THE ELDERLY: A CROSS-OVER STUDY OF A HORMONAL ANABOLIC AGENT (METHANDROSTENOLONE AND A NON-HORMONAL AGENT (ENZYME-VITAMIN COMPLEX).
    SETTEL E
    J Am Geriatr Soc; 1964 Jun; 12():538-47. PubMed ID: 14174584
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anabolic effect of methandrostenolone in geriatrics].
    LASCALEA MC; PARADA RC; BOEROMA
    Rev Asoc Med Argent; 1962 May; 76():205-11. PubMed ID: 14462572
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppressor effect of the anabolic agent methandrostenolone (Dianabol) on human pituitary gonadotropin excretion.
    WILLIAMS P; GOLDSTON N
    Bull Sci Issue; 1963 Jan; 9():7-13. PubMed ID: 24546894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.